![]() |
市場調查報告書
商品編碼
1380253
全球醫療保健預測分析市場 2023-2030Global Healthcare Predictive Analytics Market 2023-2030 |
高品質資料的獲取、組織規模、分析投資挑戰、資料準確性和資料利用率在當前的醫療保健資料分析領域發揮重要作用。 2023 年 3 月,SpectrumAi 籌集了 2,000 萬美元的 A 輪融資,由 CVS Health Ventures 領投。這筆資金將幫助這家新創公司推廣其應用行為分析(ABA)電子健康記錄、Twyll 及其網路分析平台 Patterns。對醫療保健預測分析技術的不斷成長的投資預計將為全球市場的成長提供利潤豐厚的機會。
全球醫療保健預測分析市場根據組件、部署模型和應用程式進行細分。根據組件,市場分為軟體和服務。根據部署模型,市場分為基於雲端的和本地的。根據應用,市場分為臨床資料分析、財務資料分析、研究資料分析、營運管理等。
臨床資料分析已成為醫療保健提供者中 IT 參與者關注的重要領域,他們正在轉向負責任的患者護理。臨床分析是一個利用即時醫療資料來產生見解、做出決策、增加收入和節省成本的領域。在組織中實施臨床分析減少了用藥錯誤,改善了人群健康,並為許多組織節省了成本。關鍵技術的快速進步和電子健康記錄 (EHR) 的採用導致了該細分市場的成長。隨著智慧型行動裝置和應用經濟的出現,患者期望在醫院獲得高品質的護理,這進一步促進了該細分市場的成長。
全球醫療保健預測分析市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(義大利、西班牙、德國、法國等)、亞太地區(印度、中國、日本、韓國、等)以及世界其他地區(中東、非洲和拉丁美洲)。在所有地區中,亞太地區預計在預測期內將以可觀的CAGR成長。區域成長歸因於老年人口的成長、複雜的醫療基礎設施以及對醫療分析的投資。此外,越來越多旨在促進人工智慧、機器學習和分析在醫療保健組織中應用的政府措施進一步促進了區域市場的成長。
大量老年人口極易患慢性疾病,以及醫療機構對利用預測分析來改善病患照護的興趣日益濃厚,是導致該區域市場佔有率較高的一些突出因素。預測分析平台新創公司不斷成長的資金進一步促進了區域市場的成長。例如,2021 年 7 月,總部位於辛辛那提的 Bon Secours Mercy Health 對醫療保健分析公司 Trilliant Health 進行了策略性投資。這個衛生系統的目標是加速 Trilliant 預測分析平台的開發,同時獲取有關國家和地方醫療保健趨勢的資料。
服務全球醫療保健預測分析市場的主要公司包括: Cerner Corp.、Information Builders Inc.、IBM Corp.、Oracle Corp. 和 Health Catalyst 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布)為市場成長做出巨大貢獻,以維持市場競爭力。
例如,2021 年 10 月,數位行為健康公司 SonderMind 收購了 Qntfy,這是一個預測分析平台,利用心理健康生物辨識資料來建議潛在的治療方案。 SonderMind 的平台將患者與治療師聯繫起來,進行虛擬和麵對面的就診,同時管理支付和遠距醫療套件等操作。該交易將使該公司能夠利用資料提供個人化護理,而無需為精神保健提供者帶來額外的工作。
Title: Global Healthcare Predictive Analytics Market Size, Share & Trends Analysis Report by Component (Software, Services), By Deployment Model (Cloud Based, On-premises), and by Application (Clinical Data Analytics, Financial Data Analytics, Research Data Analytics, Operations Management, and Others),Forecast Period (2023-2030).
Global healthcare predictive analytics market is anticipated to grow at a significant CAGR of 25.5% during the forecast period. Healthcare predictive analytics support healthcare organizations, hospitals, and doctors to access, analyze, and process patient data to provide data-based quality care, accurate diagnosis, and personalized treatments. In August 2023, a survey conducted by the Healthcare Information and Management Systems Society (HIMSS) and healthcare data analytics company Arcadia about the current state of healthcare analytics platforms demonstrates that less than 60 percent of health systems' data is used to inform intelligent business decisions.
Access to high-quality data, organization size, analytics investment challenges, data accuracy, and data utilization play major roles in the current healthcare data analytics landscape. In March 2023, SpectrumAi raised $20 million in Series A funding, with investment led by CVS Health Ventures. The funding will help the startup push its applied behavior analysis (ABA) electronic health record, Twyll, and Patterns, its network analytics platform. The growing investment in healthcare predictive analytics technologies is anticipated to offer lucrative opportunities for the growth of the global market.
The global healthcare predictive analytics market is segmented based on component, deployment model, and application. Based on components, the market is segmented into software and services. Based on the deployment model, the market is segmented into cloud-based and on-premises. Based on application, the market is segmented into clinical data analytics, financial data analytics, research data analytics, operations management, and others.
Clinical data analytics has emerged as a significant area of focus for IT players among healthcare providers, who are moving toward adopting accountable patient care. Clinical analytics is a field that makes use of real-time medical data to generate insights, make decisions, increase revenues, and save on costs. The implementation of clinical analytics in organizations has led to reduced medication errors, improved population health, and cost savings for many organizations. The rapid advancements in key technologies and the adoption of electronic health records (EHRs) have led to the growth of this market segment. With the emergence of smart mobile devices and the app economy, patients expect high-quality care in hospitals which has further contributed to the growth of this market segment.
The global healthcare predictive analytics market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the growing geriatric population coupled with sophisticated healthcare infrastructure along with investment in healthcare analytics. Moreover, an increasing number of government initiatives that aim to promote the application of AI, ML, and analytics in healthcare organizations are further contributing to the regional market growth.
The presence of a huge geriatric population which is highly prone to chronic disorders and the rising interest of healthcare organizations towards utilization of predictive analytics for better patient care are some of the prominent factors contributing to the high share of the regional market. The growing funding for predictive analytics platform startups is further contributing to regional market growth. For instance, in July 2021, Cincinnati-based Bon Secours Mercy Health made a strategic investment in healthcare analytics firm Trilliant Health. The health system's goal is to accelerate the development of Trilliant's predictive analytics platform, while also gaining access to data on national and local healthcare trends.
The major companies serving the global healthcare predictive analytics market include: Cerner Corp., Information Builders Inc., IBM Corp., Oracle Corp., and Health Catalyst among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
For instance, in October 2021, Digital behavioral health company SonderMind acquired Qntfy, a predictive analytics platform that uses mental health biometric data to suggest potential treatment options. SonderMind's platform connects patients with therapists for virtual and in-person visits while managing operations like payments and the telehealth suite. The deal will allow the company to deliver personalized care using data without loading that extra work on mental healthcare providers.
In the same month, Signant Health made a strategic investment in ThoughtSphere, a leading provider of data aggregation and analytics software that helps clinical trial sponsors and contract research organizations (CROs) take control over the increasing volume and variety of clinical trial data. With this investment, Signant now offers customers additional opportunities beyond data capture to cover the full continuum of the patient-data journey, up to the point of regulatory dossier and submission.